Insider Transactions in Q4 2022 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 31
2022
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
258
-1.07%
|
$2,838
$11.85 P/Share
|
|
Oct 31
2022
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.02%
|
-
|
|
Oct 21
2022
|
Ran Nussbaum Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
47,999
+3.14%
|
$239,995
$5.94 P/Share
|